Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome

J Immunol Res. 2014:2014:683160. doi: 10.1155/2014/683160. Epub 2014 Aug 20.

Abstract

X-linked hyper-IgM syndrome (XHIGM) is one type of primary immunodeficiency diseases, resulting from defects in the CD40 ligand/CD40 signaling pathways. We retrospectively analyzed the clinical and molecular features of 20 Chinese patients diagnosed and followed up in hospitals affiliated to Shanghai Jiao Tong University School of Medicine from 1999 to 2013. The median onset age of these patients was 8.5 months (range: 20 days-21 months). Half of them had positive family histories, with a shorter diagnosis lag. The most common symptoms were recurrent sinopulmonary infections (18 patients, 90%), neutropenia (14 patients, 70%), oral ulcer (13 patients, 65%), and protracted diarrhea (13 patients, 65%). Six patients had BCGitis. Six patients received hematopoietic stem cell transplantations and four of them had immune reconstructions and clinical remissions. Eighteen unique mutations in CD40L gene were identified in these 20 patients from 19 unrelated families, with 12 novel mutations. We compared with reported mutation results and used bioinformatics software to predict the effects of mutations on the target protein. These mutations reflected the heterogeneity of CD40L gene and expanded our understanding of XHIGM.

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Anemia / etiology
  • Asian People / genetics*
  • BCG Vaccine / adverse effects
  • CD40 Ligand / genetics
  • Child
  • Child, Preschool
  • China
  • Genetic Testing
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Hyper-IgM Immunodeficiency Syndrome, Type 1 / complications
  • Hyper-IgM Immunodeficiency Syndrome, Type 1 / diagnosis*
  • Hyper-IgM Immunodeficiency Syndrome, Type 1 / genetics*
  • Hyper-IgM Immunodeficiency Syndrome, Type 1 / therapy
  • Infant
  • Middle Aged
  • Mutation
  • Mycobacterium Infections / etiology
  • Prognosis
  • Transplantation, Homologous
  • Young Adult

Substances

  • BCG Vaccine
  • CD40 Ligand